-
Signature
-
/s/ Peter J. Biere
-
Stock symbol
-
IZEA
-
Transactions as of
-
Jun 30, 2023
-
Transactions value $
-
-$610
-
Form type
-
4
-
Date filed
-
7/3/2023, 04:01 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
IZEA |
Common Stock |
Options Exercise |
$0 |
+79 |
+2.28% |
$0.00 |
3.55K |
Jun 30, 2023 |
Direct |
F1 |
transaction |
IZEA |
Common Stock |
Options Exercise |
$0 |
+302 |
+8.5% |
$0.00 |
3.85K |
Jun 30, 2023 |
Direct |
|
transaction |
IZEA |
Common Stock |
Options Exercise |
$0 |
+469 |
+12.17% |
$0.00 |
4.32K |
Jun 30, 2023 |
Direct |
|
transaction |
IZEA |
Common Stock |
Tax liability |
-$610 |
-252 |
-5.83% |
$2.42 |
4.07K |
Jun 30, 2023 |
Direct |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
IZEA |
Restricted Stock Units |
Options Exercise |
$0 |
-79 |
-2.86% |
$0.00 |
2.68K |
Jun 30, 2023 |
Common Stock |
79 |
|
Direct |
F3, F4, F5 |
transaction |
IZEA |
Restricted Stock Units |
Options Exercise |
$0 |
-302 |
-12.53% |
$0.00 |
2.11K |
Jun 30, 2023 |
Common Stock |
302 |
|
Direct |
F3, F6, F7 |
transaction |
IZEA |
Restricted Stock Units |
Options Exercise |
$0 |
-469 |
-8.35% |
$0.00 |
5.15K |
Jun 30, 2023 |
Common Stock |
469 |
|
Direct |
F3, F8 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: